Close
Show
Home Articles Page 11

Articles

The knowledge-based articles provided in this section are a collection of view points from research professionals and experts concerning various aspects of Pharmaceutical industry such as Drug Research, Pharmaceutical Production and Manufacturing, Strategies, Clinical Trails and Information technology.

Delivery logistics is critical to COVID-19 vaccine availability

Delivery logistics is critical to COVID-19 vaccine availability

Print Issue April 2021 Packaging & Labelling
The opening months of 2021 have revealed the logistical and political intricacies of COVID-19 vaccine manufacturing and deployment. The unprecedented requirement of vaccinating the world against a single virus has demonstrated the power of...
COVID-19 Impact on Pharmaceutical Industry

COVID-19 Impact on Pharmaceutical Industry

MedPharm Ltd Online Topics
Despite the effects of the COVID-19 pandemic, 2020 witnessed accelerated growth taking place in the pharmaceutical contract services market which has persisted into 2021. Investment continues throughout the pharmaceutical industry, driving a need for...
Pelican BioThermal to Present at LogiPharma Europe

Air Cargo Trends in a Pandemic World

Peli BioThermal Limited Print Issue April 2021 Packaging & Labelling
Previous predictions in pharmaceutical transportation trends, highlighting declining air passenger numbers and air freight demand increasing, have been pandemic propelled. Coronavirus continues causing worldwide disruption and it is anticipated its industry impact will continue...

Solid-form development: the key to API success?

Sterling Pharma Solutions Print Issue April 2021
The success and effectiveness of an active pharmaceutical ingredient (API) solid depends on more than just its chemical make-up; the physical properties of the particles that compose the solid, play an equally important role. From...
COVID-19 Impact on Pharmaceutical Industry Comment

COVID-19 Impact on Pharmaceutical Industry Comment

ChargePoint Technology Limited Print Issue April 2021
Reflecting on the beginning of the COVID-19 outbreak 12 months ago, it is clear that those pharma companies who responded early to the warning signs – like ChargePoint Technology – were most effective at...
Time for a Truly Agile, Global Pharmaceutical Supply chain

Time for a Truly Agile, Global Pharmaceutical Supply chain

TraceLink Print Issue April 2021
Agile supply chains have distinct attributes that help manage vulnerability, disruptions and risk. Recent events demonstrate how valuable an agile process team approach can be to meet new global supply chain realities. As the COVID-19...
Fill and Finish in Clinical Development: Getting it Right from the Start

Fill and Finish in Clinical Development: Getting it Right from the Start

Vetter Print Issue April 2021
Regardless of size, pharma and biotech companies alike encounter numerous challenges in the process of fill and finish of drugs for clinical development, including any subsequent scale-up steps. These challenges encompass the increased complexity...
The rise and rise of Global Pharma Excipients Market

The impact of the COVID 19 Pandemic on Global Pharmaceutical Growth

Recipharm Online Topics
Vaccine production is very complex making specialist expertise vital to ensuring both the safety and efficacy of the final product. Depending on the type of vaccine different approaches are required. For example, a traditional...

Advancements in drug delivery

Lubrizol Life Science Health Print Issue August 2021
Advancements in drug delivery for women’s health and beyond For over two decades, Lubrizol Life Science Health (LLS Health) has been a leader in the field of women’s health, contributing to substantial advancements in the...
Russia Expects To Register Second COVID-19 'Vaccine EpiVacCorona' By Oct 15

The Impact of COVID-19 on Rare Disease Clinical Trials

Online Topics Clinical Trials
Barriers and triumphs of an underserved patient group. It is undeniable that clinical trials for rare diseases are more challenging to design and execute. Unlike trials with more frequently occurring diseases, rare disease trials have...